Lantern Pharma Inc. (LTRN) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Lantern Pharma Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.138 Good morning and welcome to our first quarter 2025 earnings call. 00:00:05.138 -- 00:00:10.164 As a reminder, this call is being recorded and all attendees are in a listen-only 00:00:10.164 -- 00:00:16.292 mode. We will open the call for questions and answers after our management's presentation. 00:00:16.292 -- 00:00:22.640 A webcast replay of today's conference call will be available on our website at lanternpharma.com 00:00:22.640 -- 00:00:28.111 shortly after the call. We issued a press release before the market opened today, summarizing 00:00:28.111 -- 00:00:33.140 our financial results and progress across the company for the first quarter ended March 00:00:33.140 -- 00:00:34.923 31st, 2025. 00:00:34.923 -- 00:00:40.480 A copy of this release is available through our website at lanternpharma.com. 00:00:40.480 -- 00:00:44.507 where you will also find a link to the slides management will be referencing on today's 00:00:44.507 -- 00:00:49.936 call. We would like to remind everyone that remarks about future expectations, 00:00:49.936 -- 00:00:55.306 performance, estimates, and prospects constitute forward-looking statements 00:00:55.306 -- 00:01:00.154 for purposes of safe harbor provisions under the Private Securities Litigation Reform 00:01:00.154 -- 00:01:02.654 Act of 1995. 00:01:02.654 -- 00:01:07.780 Lantern pharma cautions that these forward looking statements are subject to risks and 00:01:07.780 -- 00:01:13.688 uncertainties that may cause actual results to differ materially from those anticipated. 00:01:13.688 -- 00:01:18.434 A number of factors could cause actual results to differ materially from those indicated 00:01:18.434 -- 00:01:23.340 by forward looking statements, including results of clinical trials and the impac...